Table 1.
Training Cohort | Testing Cohort | |||
---|---|---|---|---|
Control (n = 55) | Aneurysm (n = 39) | Control (n = 24) | Aneurysm (n = 16) |
|
Age (Mean ± SE) | 62 ± 2.0 | 61 ± 1.7 | 59 ± 2.9 | 57 ± 3.3 |
Age [Median (Q1/Q3)] | 66 (54/72) | 60 (54/68) | 59 (54/68) | 58.5 (49.25/63.25) |
Sex (% of patients) | ||||
Female | 56.36% | 69.23% | 50% | 75% |
Smoker (% of patients) | ||||
Yes | 10.91% | 26.64% | 20.83% | 43.75% |
Comorbidities (% of patients) | ||||
Hypertension | 61.82% | 53.85% | 54.17% | 50% |
Heart disease | 30.91% | 23.08% | 25% | 18.75% |
High cholesterol | 52.73% | 48.72% | 62.50% | 50% |
Stroke history | 12.73% | 10.26% | 25% | 0% |
Diabetes | 29.09% | 17.95% | 8.33% | 31.25% |
Arthritis | 16.36% | 30.77% | 16.67% | 18.75% |
Clinical characteristics of the randomly-created training and testing cohorts. With the exception of age, these factors were quantified as binary data points. The clinical factors were retrieved from the patients’ medical records via the latest “Patient Medical History” form administered prior to imaging